Quick ReadPlain-language overview · read this first
Kratos is a U.S. defense technology company that mainly makes low-cost military drones, target drones, missile engines, and related products. This report rates the stock as "Watch," meaning the sector is attractive, but the current price is not worth buying; it belongs on a watchlist for now.
The demand it is exposed to is genuinely strong. The U.S. defense budget has reached its highest level since World War II, and "cheap but good enough" weapons are one of the clearest directions in defense procurement. The company is winning a flood of orders. The problem is profitability: after selling $100 of products, only $23 is left after cost of goods sold, and very little remains after other expenses. Its recent move into accounting profitability was driven less by a better business than by paying off debt and raising equity to build a large cash pile that earns interest. More importantly, the company is still burning cash (free cash flow has been negative for years), so the excitement is larger than the cash earnings.
Valuation is the report's biggest concern. At today's earnings level, buying the whole company would take decades to earn back the purchase price (about 74x forward earnings). It is the second-most expensive among eight peers, yet its profitability ranks last in the group. In other words, the market is paying software-company prices for a low-margin hardware manufacturer. The report views the current price of $58.52 as expensive and sees an ideal buy price below $46.
The main risks are worth watching closely: the company may issue stock again, making existing shares less valuable; it has already lost the most important Air Force drone contract, and powerful rivals are pressing back hard; the hoped-for profit inflection is not expected until 2028 and may keep failing to materialize. Management's concentrated selling near the share-price high is another negative.
In short, the demand is real and large, but a good sector has been paired with an expensive stock price. The report's judgment is to wait patiently and avoid chasing it here.
This is only a plain-English explanation of the report and is not investment advice. The stock market involves risk; invest with caution.
LeadKratos Defense is a U.S. affordable-mass defense technology pure play spanning the XQ-58 Valkyrie loyal wingman, high-speed target drones, hypersonic testbeds, solid rocket motors, and small turbofan engines. The core tension is that the company sits across almost every major unmanned-warfare theme, yet remains a low-margin, capital-intensive hardware manufacturer with only about 1.9% GAAP operating margin and years of negative free cash flow. Research rating Watch: a real defense-drone demand wave, but valuation, dilution, and margin risk leave too little safety margin at the current price.
Prices in the article are as of publication; see the valuation band above for the live price.
Research Perspective
Company: Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a San Diego-based U.S. defense technology company focused on unmanned systems (jet-powered drones and target drones), propulsion and engines, hypersonics, microwave electronics, C5ISR, space and satellite ground systems, training, and related areas.
Currency: U.S. dollars (USD). Fiscal year: Ends in late December under a 52/53-week calendar, with FY2025 ending on 2025-12-28.
Price anchor: All relative valuation work in this report uses the 2026-06-05 closing price of $58.52 on NASDAQ as the baseline, down 7.70% that day from a previous close of $63.40. Market capitalization was about $10.97B, shares outstanding about 187.52M, trailing PE about 373x, forward PE about 74x, and the 52-week range was $37.90 – $134.00. That means the stock was down about 56% from its 52-week high and about 54% above its low. The price was confirmed through stockanalysis.com and EODHD with exact real-time consistency; the WebSearch figure of $59.72 was an internally inconsistent outlier and is not used (stockanalysis).
Data basis: Financial data come from the company's primary SEC filings, including the FY2025 10-K, Q1'26 8-K/10-Q, earnings releases, and 424B5 prospectus supplements. Industry, peer, and stock-price data are cross-checked against authoritative secondary sources. Key accounting note: 1. "Adjusted EBITDA" and "adjusted EPS" are non-GAAP metrics emphasized by the company and differ materially from GAAP operating income and EPS; this report presents both and does not mix them. 2. Kratos has shifted to a net cash position, so EV multiples are depressed by net cash, but they remain extreme.
1. Conclusion First
Rating: Watch. Ideal buy price ≤ $46, roughly equivalent to 4.2x FY26E EV/revenue or about 42x forward adjusted EBITDA, about 21% below the current price.
Kratos is a classic case of the right market, real growth, wrong price. The Watch rating, rather than Buy or Avoid, rests on five independent points:
The market and order book are genuinely strong. "Affordable mass" is one of the clearest structural themes in defense today. The FY2027 defense budget is $1.5 trillion, the highest since World War II and up about 42% YoY; munitions procurement is up about 185% YoY; and the new Defense Autonomous Warfare Group, or DAWG, replacing Replicator, has an FY27 R&D request of about $54.6 billion (CSIS FY27 topline; Breaking Defense DAWG). Kratos is positioned across almost every major theme, and order data support the case: Q1'26 book-to-bill of 1.6x, record backlog of $2.01 billion, organic growth of +15.8%, and a $14.3 billion bid pipeline (Kratos Q1'26 8-K).
Margins are extremely thin, cash flow is negative, and ROIC is about 1%. FY2025 gross margin was only 22.9%, while GAAP operating margin was only about 1.9%. GAAP net income swung from −$8.9 million in FY2023 to +$22.0 million in FY2025, mainly because the company paid off all debt and built about $1.46 billion of cash through two equity offerings, generating interest income, rather than because operating performance improved. Q1'26 net income of $11.9 million was already above operating income of $4.7 million (Kratos Q1'26 8-K). Free cash flow has been negative for years, including −$125 million in FY25 and FY26 guidance of −$85 million to −$105 million. ROIC is about 1.15% (Simply Wall St). These are the economics of a subscale, capital-intensive defense contractor, not a wide-moat compounding machine.
Valuation and business profile are badly mismatched. The current price implies 373x trailing PE, about 74x forward PE, 6.85x EV/revenue, about 119x EV/GAAP EBITDA, and about 73x EV/adjusted EBITDA. Among eight publicly traded defense peers, EV/revenue, EV/EBITDA, and forward PE are all the second highest, behind only Palantir, while EBITDA margin is the lowest in the group (stockanalysis valuation page). The market is pricing a hardware company with about 9% EBITDA margin like a software stock.
The narrative has hard flaws: a flagship loss and a powerful rival pressing back. The most important USAF CCA Increment 1 program was lost. In 2024 it went to General Atomics and Anduril, and Kratos was not even among the five initial selections (DefenseScoop). Anduril, now valued at $61B, is attacking Kratos's own affordable-mass thesis from the opposite direction with vertical integration, software-like gross margins, and automotive-scale production capacity (TechCrunch).
Capital allocation signals are negative. To fund capacity expansion and M&A, Kratos completed two equity offerings totaling about $1.75 billion within 18 months, in 2025-06 at $38.50 and in 2026-02 at $84.00, increasing the share count by about 24%. CEO Eric DeMarco also sold heavily under a 10b5-1 plan near the January 2026 stock-price peak, with sales totaling about $63.4 million over the past six months (MarketBeat).
One-sentence view: The defense-drone and affordable-mass demand wave is real, large, and worth tracking for years, but Kratos today combines full valuation, thin margins, negative free cash flow, and repeated dilution. Even after a roughly 56% drawdown from the $134 high, a 74x forward PE still prices in years of flawless execution and a 2028 margin inflection from contract repricing. Wait for proof of margin and free-cash-flow inflection, or for the price to return below $46, before acting.
2. Company Profile
Core businesses and two reporting segments. Kratos reports through two segments (FY2025 10-K):
Kratos Government Solutions (KGS), FY2025 revenue of $1,054.8M, 78.3% of total, up 21.8%. This includes microwave electronics, space/satellite and cyber, training, C5ISR/modular systems, turbine technologies, meaning jet engines and propulsion, and defense and rocket support services, including hypersonics and solid rocket motors. This is the real revenue and growth engine.
Unmanned Systems (KUS), FY2025 revenue of $292.0M, 21.7% of total, up 7.9%. This includes the XQ-58 Valkyrie loyal wingman/CCA, BQM-167/177 high-speed target drones, loitering munitions, and related products. It is almost entirely hardware, with services contributing only $8.7M.
Key perception gap: Although "drones/Valkyrie" dominate the market narrative, the Unmanned segment contributes only about 22% of revenue. The real propulsion/engine, hypersonics, solid rocket, microwave electronics, and space ground-system businesses are all housed within KGS. Q1'26 confirms this: KUS contributed $82.6M, with organic growth of +30.9% from a smaller base, while KGS contributed $288.4M, with organic growth of +11.8% and most of the revenue base.
Revenue model and customers. About 68% of revenue comes from the U.S. government and Department of Defense in FY2025, including 17.7% from the Navy and 12.6% from the Air Force. International revenue is about 17%, and U.S. commercial and other revenue is about 11%. Kratos works as both prime contractor and subcontractor. About 69% of revenue comes from fixed-price contracts, mostly production contracts, with the rest from cost-plus and T&M contracts. Customers are highly diversified: no single contract accounts for more than 5% of revenue, and no single customer other than the U.S. government accounts for more than 10% of revenue (FY2025 10-K).
Core growth franchises: 1. XQ-58 Valkyrie / CCA, which won the U.S. Marine Corps MUX TACAIR CCA through Northrop Grumman in 2026-01, worth about $231.5M over 24 months, with a plan to produce about 40 aircraft per year starting in late 2027. 2. Hypersonics, including MACH-TB 2.0, a $1.45 billion, five-year award and the largest single contract in company history, plus Erinyes/Dark Fury vehicles. 3. Solid rocket motors (SRM), including the in-house Zeus 32.5-inch motor, with an L3Harris LOI in 2025-12 for 60 production units, split between 40 Zeus 1 and 20 Zeus 2 units. 4. Affordable jet propulsion, including the GEK800 small turbofan co-developed with GE Aerospace for low-cost cruise missiles and drones. 5. Steady niche businesses in microwave electronics and space/satellite systems, including OpenSpace software-defined ground systems.
Management and ownership. CEO Eric M. DeMarco has led the company since 2004-04, after joining the then Wireless Facilities as President/COO in 2003. His tenure is about 22 years, and he also serves as President, with no independent company-level COO. CFO is Deanna H. Lund. Segment presidents include Steve Fendley for Unmanned Systems and David Carter for DRSS. Management and insiders own about 1.45% in total, with CEO DeMarco personally owning about 1.06 million shares, less than 1%. Management skin in the game is modest. Institutional ownership is about 82–88%, including Vanguard at about 10.5% and BlackRock at about 8.7% (BusinessQuant; Simply Wall St).
3. Longitudinal Analysis: History and Stock-Price Path
Origins and transformation. Kratos began as communications outsourcing company Wireless Facilities Inc. In 2007-09, it formally changed its name to Kratos Defense & Security Solutions and began trading on Nasdaq under KTOS. At the time, its federal business had annualized revenue of about $200 million (GlobeNewswire name-change release). What followed was a two-decade acquisition-driven roll-up: Henry Bros. in 2010 for security integration; Herley Industries in 2011 for microwave/electronic warfare, about $270.7M; Integral Systems in 2011 for satellite command-and-control software; Composite Engineering/CEI in 2012 for about $155M, the foundation of the target-drone business that later incubated XQ-58 Valkyrie; 5-D Systems in 2020 for jet-drone software; Orbit Communications in 2025 for satellite communications, about $356M; Nomad in 2026-02; and others.
Revenue and thin-margin trajectory. Total revenue rose from about $542 million in FY2016 to $1.347 billion in FY2025, a roughly 10.6% CAGR over about nine years and about 12.5% over the past five years. Yet net income has hovered near breakeven for years: −$8.9 million in FY2023, +$16.3 million in FY2024, and +$22.0 million in FY2025. This is the source of the 373x trailing PE: an $11.0 billion market cap divided by TTM net income of about $29.4 million.
The 2024 to 2026 surge and collapse, the core of this dimension. KTOS traded for years around $15–25. In 2025 it rose about 190%, from roughly $26 to $76. In the first two weeks of 2026, it surged further to a mid-January 2026 closing price around $131 and an intraday 52-week high of $134.00. Catalysts stacked together: the $1.45 billion MACH-TB award, drone/Valkyrie enthusiasm, Trump's roughly $1.5 trillion defense-budget proposal, the 2026-01-08 USMC CCA win, inclusion in the S&P MidCap 400 on 2025-09-22, and Stifel's $134 price target (Insider Monkey). The stock then fell about 56% to $58.52, driven by extreme valuation compression, the large $1.2 billion dilutive offering at $84.00 in 2026-02, negative Q1'26 free cash flow, "good news sold" after Q1 beat and raised guidance but the stock still fell about 9.6%, and broad market de-risking on 2026-06-05. That day, Nasdaq fell 4%, the Philadelphia Semiconductor Index fell 9%, Broadcom guidance and strong payroll data pushed rates higher, and high-multiple momentum stocks were broadly de-rated, with KTOS down 7.7% and AVAV down 9% (Motley Fool; stockstory).
Equity offerings and dilution. Kratos completed three underwritten equity offerings within 25 months: 2024-02 at $18.00, about 16.67M shares and about $300 million; 2025-06 at $38.50, about 14.9M shares and $575 million including a $500 million base offering plus overallotment; and 2026-02 at $84.00, about 16.4M shares including overallotment and net proceeds of about $1.17 billion. The last two offerings together raised about $1.75 billion, with the largest round priced at $84 shortly after the January peak. Share count moved from about 130M in FY2023 to about 151M in FY2024, about 169M at FY2025 year-end, and about 187.5M currently, implying about +24% dilution over 18 months. Authorized shares are 195M, so the company is already near the cap (424B5).
4. Financial Review
Period income statement ([P] company earnings releases / SEC 8-K):
| Metric | FY2023 | FY2024 | FY2025 | TTM through Q1'26 | Q1 FY2026 |
|---|---|---|---|---|---|
| Total revenue | $1,037.1M | $1,136.3M | $1,346.8M | ~$1,415.2M | $371.0M |
| YoY reported | +15.5% | +9.6% | +18.5% | +21.8% | +22.6% |
| Organic growth | +12.6% | ~nearly all organic | +16.6% | — | +15.8% |
| Gross margin | 25.9% | 25.3% | 22.9% | ~22.9% | 24.1% |
| GAAP operating income | $31.1M | $29.0M | $25.6M | ~$23.7M | $4.7M |
| Operating margin | 3.0% | 2.6% | 1.9% | ~1.7% | 1.3% |
| Adjusted EBITDA | $95.4M | $105.7M | $119.9M | ~$131.9M | $38.7M |
| Adjusted EBITDA margin | ~9.2% | ~9.3% | 8.9% | ~9.3% | 10.4% |
| GAAP net income | −$8.9M | $16.3M | $22.0M | ~$29.4M | $11.9M |
| Diluted EPS | −$0.07 | $0.11 | $0.13 | ~$0.16 | $0.07 |
| Adjusted EPS | — | $0.49 | $0.55 | — | $0.16 |
(FY2025/Q1'26 data: Kratos FY2025 release, Q1'26 release; TTM = FY2025 − Q1'25 + Q1'26.)
Earnings-quality warning, the key point: GAAP operating income has declined in absolute terms year by year, from $31.1M to $29.0M to $25.6M, while revenue rose about 30% over three years. Growth has been bought with spending. GAAP net income turned positive mainly because of balance-sheet restructuring rather than operating improvement: 1. In 2025, the company paid off all traditional debt, redeeming $300M of 6.5% notes and repaying a $177.5M Term Loan A, saving about $25–30M per year in interest. 2. Two equity offerings built about $1.46 billion of cash, generating meaningful interest income. Evidence: Q1'26 net income of $11.9M already exceeded operating income of $4.7M, with the difference mainly from cash interest income. In other words, a large portion of current GAAP "profit" is interest income, not operating profit.
Orders and backlog. Q1'26 total backlog was $2.010B, a record, including funded backlog of $1.457B plus unfunded backlog. Bookings were $605.2M, book-to-bill was 1.6x, LTM book-to-bill was 1.2x, and the bid pipeline was $14.3B (Q1'26 8-K). Backlog rose from $1.445B in FY2024 to $1.573B in FY2025 and $2.010B in Q1'26, which is the strongest pillar for the bull case. The caveat: $2.01B of backlog is only about 1.2 times annualized revenue, so revenue visibility is lower than at prime contractors.
Balance sheet, now net cash. Q1'26 cash and equivalents were $1,464.3M, traditional debt was $0, finance leases were $136.8M, net cash was about $1.28B, and shareholders' equity was $3,410.0M.
Cash flow and capital expenditure, with FCF persistently negative and worsening:
| Period | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|
| FY2024 | +$49.7M | $58.2M | −$8.5M |
| FY2025 | −$42.1M | $95.3M | −$125.4M |
| Q1'26 | −$27.4M | $19.9M | −$43.1M |
| FY2026 guidance | +$60M~$70M | $155M~$165M | −$85M~−$105M |
(Note: Free cash flow is shown using the company's definition. FY2025 = operating cash flow of −$42.1M − capex of $95.3M + Valkyrie aircraft-sale proceeds of $12.0M = −$125.4M. Q1'26 on the same basis = −$47.3M + $4.2M = −$43.1M. Under the textbook "operating cash flow − capex" definition, FY2025 would be −$137.4M. Under either definition, FCF is deeply negative.)
Capex has nearly tripled over three years, from $58M to $95M to guidance of about $160M. It is being spent on a second Valkyrie production line, solid-rocket/hypersonic facilities, the BladeWorks turbofan facility, and related capacity. The company is clearly in a phase of "building capacity ahead of 2027+ demand and sacrificing near-term FCF." FY2026 total investment guidance, including capex, working capital, and Prometheus JV funding, is $248–270M (Q1'26 release).
FY2026 guidance, raised after Q1 and including Orbit/Nomad consolidation: Revenue of $1,700–1,760M, raised from $1,595–1,675M; adjusted EBITDA of $170–176M, raised from $157–167M; operating cash flow of $60–70M; capex of $155–165M; and free cash flow of −$85M to −$105M. GAAP operating income is only about $18–23M.
5. Moat
Conclusion: narrow moat, with some growth engines still more narrative than moat. The only clearly verifiable narrow moat sits in one corner of the business. Other engines being priced into the high valuation are currently competitive bid positions rather than protected profit pools.
(a) Real but no-pricing-power sole source: high-speed target drones. The BQM-167A for the Air Force and BQM-177A for the Navy are Kratos's only clearly verifiable sole-source franchise. In 2024-09, the Air Force awarded a $79.8M sole-source contract for 60 BQM-167A Lot 20 aircraft, the largest single lot in the history of the Life Cycle Management Center (asdnews). A decade-scale program position and airworthiness certification are real barriers. The irony is that this very batch sits inside a multi-year fixed-price contract where inflation has eaten margins and repricing does not arrive until 2028. FY2025Q4 consolidated gross margin fell from 25.1% to 22.2%. A sole-source supplier with genuine pricing power would not lose money on its flagship product until 2028.
(b) "Affordable mass" is a thesis, not a moat. Kratos says it has about 40% share in tactical jet drones, and the CEO has cited a CCA price point of about $10M per aircraft (armyrecognition). Low cost by itself is not a moat. It invites price competition. "Attritable" means low unit price, high capital intensity, and thin margins, which creates commodity-style pressure.
(c) The biggest challenge: CCA loss plus Anduril. ⚠️ Verified as true: USAF CCA Increment 1 in 2024 was awarded exclusively to General Atomics and Anduril. Kratos lost and was not even among the five initial selections (CSIS). The claim that "Kratos = CCA winner" is wrong for the most important Air Force program. Fair offsets: In 2026-01, the U.S. Marine Corps selected Northrop + Kratos's XQ-58 for its first operational CCA; Kratos is also working with Airbus on a German derivative and was included in the Air Force CCA Increment 2 concept refinement list of nine vendors (Defense News). Net assessment: Kratos remains at the table, but it already lost the most important Inc 1 program, and Inc 2 is a crowded bid rather than a protected position. Anduril, valued at $61B, with vertical integration, Lattice software, an automotive-style Arsenal-1 factory, and its own SRM plant, is using stronger capital to press back along Kratos's own affordable-mass thesis (Sacra).
(d) Propulsion and engines: call option, not current moat. GEK800 is a teaming arrangement with GE Aerospace, where GE is the lead party. For Air Force Inc 2 engines, awards in 2026-02 went to four companies at once. GE-Kratos received only $12.4M for preliminary GEK1500 design work, alongside Honeywell and Pratt & Whitney. Engines are competitive and multi-sourced, not exclusive (FlightGlobal).
(e) The decisive durability risk: extremely low returns on capital. Q1'26 operating margin was only about 1.3%, operating cash flow was −$27.4M, and FCF was −$43.1M. ROIC is about 1.15% and declining year by year (Simply Wall St). These are the economics of a subscale, capital-intensive, low-margin defense contractor. They cannot support the wide-moat compounding-machine assumption embedded in a 74x forward PE. In addition, several growth lines depend on larger players' capacity and brands: Kratos provides platforms to Northrop, engines with GE, and Zeus to L3Harris for outsourced production. Its bargaining position is weak and vulnerable to prime-contractor pressure.
6. Industry Demand
The demand wave is real and large, but signed contract dollars still fall well short of an ~$11B valuation.
(a) Strong defense-budget tailwind. FY2026 defense appropriations of $838.7B passed the House in 2026-02 and ended the shutdown, alongside about $150 billion of reconciliation funding from the One Big Beautiful Bill Act, or OBBBA. The FY2027 budget top line is about $1.5 trillion, the highest since World War II and up about 42% YoY, including $76.3 billion of munitions procurement, up about 185% YoY (CSIS).
(b) Replicator to DAWG plus lessons from Ukraine. Replicator, launched in 2023, fell short because systems were unreliable, too expensive, and too slow. It was dissolved at the end of 2025 and folded into the newly created Defense Autonomous Warfare Group (DAWG), with an FY27 R&D request of about $54.6 billion (Defense One). Ukraine produced about 4 million drones in 2025 and consumes about 5,000 FPV drones per day. The affordable-mass doctrine directly benefits Kratos's low-cost drone and target-drone DNA.
(c) CCA: absent from the main line, positioned on the edges. The CCA program targets at least 1,000 aircraft and about $8.9 billion across the FYDP. Increment 1 in 2024 went to GA + Anduril, whose prototypes had already flown in 2025. Kratos is absent from the main line. Increment 2 entered concept refinement in 2025-12 with nine vendors selected, and Kratos is participating through XQ-58 + GE engines (Breaking Defense).
(d) Golden Dome missile defense. The 2025-01 executive order launched the program. The White House cited about $175 billion, while the CBO estimated $1.2 trillion over 20 years. Kratos has already won a $446.8M Space Force SSC OTA for resilient missile warning and tracking ground management and integration, or GMI, and should also benefit through target drones, hypersonic testbeds, and Zeus SRM exposure (Breaking Defense).
(e) Hypersonics and domestic propulsion localization. MACH-TB 2.0, worth $1.45 billion over five years, aims to reach one flight test per month. A second source for solid rocket motors, breaking the Aerojet/Northrop duopoly, and domestic small-turbofan production, reducing reliance on a single supplier, are both policy-favored directions.
(f) Headwinds. Continuing resolutions, government shutdowns, and delays in reconciliation funding matter because OBBBA funds will be spent gradually over five years. Programs are lumpy. At the low end, Ukraine-style $400 FPV drones create "cost per effect" pressure. At the high end, rivals have taken the main CCA line.
Balanced view: demand is large and durable, but the narrative is ahead of contracted dollars. Kratos's positioning and TAM support a multi-year tailwind, but backlog is only about 1.2 times annual revenue, FY26 revenue is only about $1.7 billion, and FCF is negative. To grow into an $11.0 billion valuation, the company needs several consecutive years of 20%+ growth plus meaningful margin expansion. The most certain large award, MACH-TB, is a lower-margin test-service contract, while the main CCA line is absent.
7. Peer Comparison
Comparable-company valuation, based on 2026-06-05 close and [S] stockanalysis/finviz cross-checks:
| Company | Market cap | TTM revenue | Revenue growth | EBITDA margin | PE trailing | PE forward | EV/EBITDA | EV/revenue |
|---|---|---|---|---|---|---|---|---|
| KTOS (drones/propulsion/hypersonics) | $10.97B | $1.42B | +21.8% | lowest in group ~5.7% | 373x | ~74x | 119x | 6.85 |
| AVAV (small-drone pure play) | $9.37B | $1.61B | +116.9%† | 9.4% | loss-making | 47x | 63.6x | 5.97 |
| PLTR (defense software, expensive benchmark) | $324.9B | $5.22B | +67.7% | 38.6% | 152x | 86x | 157x | 60.7 |
| DRS (defense electronics) | $12.31B | $3.70B | +10.5% | 12.5% | 43x | 36x | 26.5x | 3.32 |
| LMT (prime contractor) | $120.8B | $75.11B | +4.6% | 10.6% | 25x | 17x | 17.5x | 1.86 |
| NOC (prime contractor) | $77.32B | $42.37B | +5.0% | 17.3% | 17x | 19x | 12.6x | 2.18 |
| RTX (prime contractor) | $243.7B | $90.37B | +10.6% | 16.9% | 34x | 26x | 18.1x | 3.05 |
(†AVAV's TTM +116.9% growth is driven by the BlueHalo acquisition and is not organic. Organic growth is about +14.5%; GAAP earnings are negative, so there is no TTM PE. Source: stockanalysis.)
KTOS valuation positioning, quantified. Placing KTOS among peers yields a consistent conclusion: it is priced as a hypergrowth software/defense-tech stock, while its underlying business is capital-intensive, low-margin hardware manufacturing.
EV/revenue of 6.85x is the second highest in the group, behind only PLTR at 60.7x. It is about 2.1 times DRS at 3.32x and 3.7 times prime contractor LMT at 1.86x, and already slightly above the closest drone pure play, AVAV at 5.97x.
EV/EBITDA of 119x is the second highest in the group, about 4.5 times DRS and 7 times the primes. This is the most jarring metric because KTOS has the lowest EBITDA margin in the group, so the denominator is extremely small and the multiple explodes.
Forward PE of ~74x is the second highest in the group, above AVAV at 47x and about twice DRS at 36x.
Core tension: KTOS simultaneously has the "lowest EBITDA margin in the group" and the "second highest valuation multiple" across all three major valuation measures. Compared with DRS, which has similar growth of about 10–13%, KTOS trades at about twice the forward PE even though DRS has more than twice the EBITDA margin. KTOS receives software valuation, but reports low-margin hardware economics.
Private-market benchmark, for context only. Anduril raised $5.0 billion in a 2026-05 Series H at a $61B valuation, doubling in nine months. 2025 revenue was about $2.2B, implying about 28x EV/revenue (CNBC). This shows that private markets do assign software-like multiples to defense-tech pure plays, which provides a contextual anchor for KTOS's high multiple. Private-market valuations cannot be directly transferred to public equities.
Sell-side coverage, with targets mostly lagging the drawdown. Consensus rating is "Buy", with an average target price of about $113, updated on 2026-05-11 and ranging from $75 to $150. Versus the current $58.52 price, that implies about +90% upside. This enormous gap itself signals that targets are lagging the stock-price drawdown. Recent revisions are mostly downward: RBC cut its target from $100 to $80 and reduced its EBITDA multiple assumption from 65x to 50x, citing continued contract-award timing delays; Jefferies moved to about $80–85 (Yahoo/RBC). The stock has already de-rated ahead of the sell side, and targets are still catching up.
8. Current Fundamentals
Latest quarter: Q1 FY2026, reported on 2026-05-06 for the period ended 2026-03-29:
| Item | Actual | Comparison |
|---|---|---|
| Revenue | $371.0M, +22.6% YoY, organic +15.8% | Beat by about $24.7M versus consensus of about $346M |
| Adjusted EPS | $0.16, GAAP $0.07 | Beat consensus by about $0.14 |
| Adjusted EBITDA | $38.7M, with operating income only $4.7M and net income $11.9M | — |
| Orders/backlog | book-to-bill 1.6x, bookings $605.2M, backlog $2.010B, pipeline $14.3B | — |
| Cash flow | Operating cash flow −$27.4M, free cash flow −$43.1M | Still negative |
| FY2026 guidance, raised | Revenue $1,700–1,760M, adjusted EBITDA $170–176M | GAAP operating income only $18–23M |
"Good news sold" is the most important current market signal. Q1 revenue and EPS beat consensus, and full-year guidance was raised, yet the stock still fell about 9.6%. The market is focused on cash burn and dilution rather than growth. This matches the move after Q4'25 on 2026-02-23: Q4 beat expectations, but soft first-quarter guidance plus the announced equity offering triggered selling.
Valuation optics as of 2026-06-05: EV was about $9.69B, based on market cap minus $1.28B of net cash. EV/TTM revenue was 6.85x, EV/TTM adjusted EBITDA about 73x, EV/TTM GAAP EBITDA about 119x, trailing PE 373x, and forward PE ~74x (stockanalysis valuation page). PE is extremely high because TTM GAAP net income is only about $29.4 million against an approximately $11.0 billion market cap, and operating margin is only 1–3%, with most revenue consumed by cost and investment.
Capital allocation and governance signals. There are no obvious major related-party or accounting red flags, with ISS QualityScore at 4. Still, heavy insider selling at high prices is the main blemish. CEO DeMarco sold about $18.05 million in 2026-01 at around $90 and about $16.10 million in 2025-12 at around $80, totaling about $63.4 million over the past six months. The 10b5-1 plan was established on 2025-08-29, just before the peak. CFO Lund and other executives also sold. Combined with management's opportunistic equity issuance at a high valuation, this creates the negative combination of "the best-informed people selling and issuing stock at high prices" (Investing.com).
9. Valuation
Method: EV/revenue and EV/adjusted EBITDA are the main anchors because GAAP earnings are too thin and PE is distorted; DCF is used only as a directional check. Current price is $58.52, net cash is $1.28B, share count is 187.52M, FY2026E revenue is about $1.73B, and FY2026E adjusted EBITDA is about $173M, based on the midpoint of guidance.
| Scenario | Price range | Implied EV/FY26E revenue | Key assumptions |
|---|---|---|---|
| Bear | $32 – $42 | ~3.0–3.5x | Multiple converges toward normal defense hardware levels, with DRS at ~3.3x; further dilution; another CCA Inc 2 loss; near the 52-week low of $37.90 |
| Base | $45 – $60 | ~4.2–5.5x | Reasonable premium for high growth and the defense theme; 20%+ growth continues but margin expansion is slow and FCF remains weak |
| Bull | $72 – $95 | ~6.5–8.0x | Flawless execution; 2028 contract repricing drives margin inflection; CCA Inc 2 / Golden Dome scales; corresponds to recently cut sell-side targets around $80 through a more optimistic range |
Ideal buy price ≤ $46, the lower half of the base range, roughly 4.2x FY26E EV/revenue or about 42x forward adjusted EBITDA, about 21% below the current price. This leaves a margin of safety for a still-unproven margin and FCF inflection.
The current price of $58.52 sits near the top of the base range, $45–60, meaning it is fully priced and slightly expensive. This is consistent with extreme multiples of 373x trailing PE, 74x forward PE, and 6.85x EV/revenue. Even after a roughly 56% drawdown, valuation still prices in years of perfect execution. Sell-side consensus of $113 sits above the bull range and looks over-optimistic or stale. The recently cut $80 target sits inside the bull range. Absolute boundary note (YMYL): this section is a research framework, not investment advice. Defense order timing is lumpy, dilution remains an overhang, and interest income is a large share of net income, making any point valuation highly uncertain.
10. Risks, Including Pre-mortem
Number-one risk: valuation. Forward PE is about 74x, EV/revenue is 6.85x, and EV/EBITDA is 119x for a capital-intensive hardware company with about 23% gross margin and about 1–2% GAAP operating margin. The multiple prices in years of flawless execution. Any contract delay, capacity ramp miss, or failure to expand margins will be amplified by the high multiple.
Pre-mortem: if the stock falls sharply over the next 18 months, the most likely scenarios are:
Another dilutive equity offering, the highest-probability overhang. FY26 FCF guidance remains −$85 million to −$105 million, and management has explicitly discussed opportunistic financing. Another share issuance would add to the existing +24% dilution and pressure EPS and valuation.
CCA Increment 2 prototype loss, repeating the Inc 1 failure and puncturing the "drone leader" narrative.
Margin inflection delayed. Fixed-price contract cost overruns and a rising mix of low-gross-margin production could push out the bull case of 2028 repricing plus margin expansion.
Broad market de-risking. As a high-beta momentum stock, KTOS remains exposed to valuation compression on rate-up or risk-off days, as seen on 2026-06-05.
Pressure from Anduril and other strong rivals. Anduril, with a $61B valuation, vertical integration, and software-like gross margins, is pressing back into the affordable-mass market and could erode Kratos's share and pricing.
Other risks: execution and capex risk, including years of negative FCF and diluted ROIC; program concentration and dependence on the U.S. budget, including continuing resolutions, shutdowns, and program delays; gross-margin risk from fixed-price contracts that cannot reprice until 2028; and governance optics from heavy insider selling at high prices.
11. Catalyst Watchlist
Positive catalysts over the next 6–18 months:
USAF CCA Increment 2 prototype down-select. Kratos is competing with XQ-58 + GE engines. Any selection would be a re-rating catalyst.
Golden Dome follow-on orders. After the $446.8M Space Force GMI award, incremental target-drone, SRM, and hypersonic-test orders could follow.
Hypersonic milestones. Flight-test cadence and incremental task orders under MACH-TB 2.0, worth $1.45 billion.
Propulsion/SRM scaling. Zeus, including the L3Harris 60-unit LOI; Oriole, a $49M Navy award in 2026-03; and GEK800 turbofan production targeted for mid-2026.
Quarterly book-to-bill remaining above 1.2, backlog growth, FY2027 defense-budget enactment, 2H2026 margin inflection plus 2028 fixed-price repricing, and Orbit/Nomad integration execution.
Negative catalysts: another dilutive equity offering, continuing resolutions, government shutdowns, budget delays, another CCA Inc 2 loss, fixed-price cost overruns, continued insider selling, and risk-off trading days.
12. Zen Horizon Synthesis
Combining the longitudinal view, meaning history and stock-price path, with the horizontal view, meaning peers and valuation, produces one unified judgment on Kratos:
Longitudinally: This is a defense-hardware company transformed from a communications outsourcer through a two-decade roll-up. Revenue compounded at about 10.6% over nine years, but net income has long hovered near breakeven. In 2025–2026, the affordable-mass narrative, the $1.45 billion MACH-TB award, and defense-budget expectations drove the stock up about 5–6 times to $134 in a little over a year. Then extreme valuation, repeated dilution, negative FCF, and broad market de-risking drove a roughly 56% collapse. Its earnings curve is far less attractive than its stock-price curve.
Horizontally: Among eight publicly traded defense peers, KTOS has the second highest EV/revenue, EV/EBITDA, and forward PE, behind only Palantir, while also having the lowest EBITDA margin in the group. The market values it like a software stock, while the fundamentals are low-margin hardware.
Synthesis: Kratos's market purity and order momentum are real and large. But the market is right and the price is wrong. A 74x forward PE prices an unproven margin inflection, a string of future wins not yet secured, and a flagship program already lost as if they were facts. Compared with other "good market, bad price" names in this framework, such as besi and SDGR, KTOS has weaker business quality, with ROIC of about 1% and years of negative FCF, but higher sector optionality and a thicker net-cash balance. That is why the rating is Watch rather than Buy, because there is no safety margin, and also not Avoid, because the market is real, growth is real, and bankruptcy risk is low. This belongs on a watchlist for a margin/FCF inflection or a cheaper entry price, not as a current buying opportunity.
Research Uncertainties
FY2025 free-cash-flow definition: This report uses the company's official definition of −$125.4M, calculated as operating cash flow of −$42.1M minus capex of $95.3M plus Valkyrie aircraft-sale proceeds of $12.0M. Under the textbook "operating cash flow − capex" definition, the figure would be −$137.4M. Both definitions confirm deeply negative FCF, and this report uses the company definition consistently with Q1'26 at −$43.1M and FY26 guidance.
Forward PE range of ~55x–74x: finviz uses a more aggressive forward EPS estimate, producing about 55x, while stockanalysis and commissioned verification point to about 74x because of EPS-methodology differences. This report uses 74x, and the conclusion holds at both ends.
Precise contribution of interest income to net income: This is inferred from the gap between operating income and net income, using about $1.46 billion of cash at roughly 4%, rather than disclosed by the company as a detailed line-item split. The qualitative conclusion is reliable, but the exact split is an estimate.
Peak price: $134.00 was the 52-week intraday high, and the peak close was about $131 in mid-January 2026. This is consistent across multiple sources, though daily trade-level exchange data were not used.
Institutional ownership percentages: Vanguard, BlackRock, and other holders report on different 13G dates, and the company went through two large equity offerings. Percentages need to be recalculated using the then-current share count of about 187.5M before direct comparison.
YMYL note: This report is research analysis, not investment advice. The price anchor is the 2026-06-05 close. Defense order timing is lumpy, equity issuance remains an overhang, and point valuation is highly uncertain.
This research applies the Zen Horizon Framework. Conclusions are based on public information through 2026-06-07 and the 2026-06-05 closing-price anchor. All load-bearing data were cross-checked against primary SEC filings or at least two independent sources. The research perspective is third-party independent analysis and does not constitute investment advice.
This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.
Full report
Sign in to read the full report
Sign up free to unlock the full text, the Baillie growth scorecard, and full-text search.
Log in / Sign up free